Browse our anti-FABP4 (FABP4) Antibodies

Human Fatty Acid Binding Protein 4, Adipocyte (FABP4) interaction partners

1. A-FABP is positively correlated with aortic arterial stiffness in patients with T2DM

2. FABP4 accelerates glioblastoma cell growth and metastasis through Wnt10b signalling.

3. these results indicate that FABP4 low-expression plays a critical role in the proliferation and metastasis of HCC cells, and maybe a biomarker for HCC diagnosis and prognosis, and may provide an emerging therapeutic target for HCC in future.

4. Circulating A-FABP levels predict the development of subclinical atherosclerosis in type 2 diabetes patients.

5. Circulating adipose fatty acid binding protein (A-FABP) promotes obesity-associated breast cancer development. A-FABP released by adipose tissue directly targeted mammary tumor cells, enhancing tumor stemness and aggressiveness through activation of the IL-6/STAT3/ALDH1 pathway.

6. FABP4 concentration is an independent predictor of the progression of carotid atherosclerosis.

7. Circulating AFABP levels were predictive of incident adverse renal outcomes, even in participants with relatively well-preserved kidney function at baseline, suggesting its potential to be a useful marker for early risk stratification in DKD.

8. These findings identify A-FABP as a functional marker for protumor macrophages, thus offering a new target for tumor immunotherapy

9. The emerging oncogenic role of liver endothelial cells through FABP4 in HCC related to MS.

10. In cardiovascular disease patients, the pericardial cavity is a distinct adipocytokine microenvironment in which especially FABP4 is mainly derived from the heart.

11. Thus, FABP4 overexpression in hepatic stellate cells may contribute to hepatocarcinogenesis in patients with metabolic risk factors by modulation of inflammatory pathways.

12. These results demonstrated that loss of A-FABP expression following a long follow-up was predictive of non-muscle invasive bladder cancer progression

13. Patient serum analysis demonstrated significantly increased FABP4 in those with underlying liver disease, particularly non-alcoholic fatty liver disease and hepatocellular carcinoma. This suggests FABP4, an FABP not normally expressed in the liver, can be synthesized and secreted by hepatocytes and HCC cells, and that FABP4 may play a role in regulating tumour progression in the underlying setting of obesity.

14. the expression of FABP4 might have a prognostic value in patients with breast cancer

15. Inhibition of MIR31HG reduced the enrichment of active histone markers, histone H3 lysine 4 trimethylation (H3K4me3) and acetylation (AcH3), in the promoter of the adipogenic-related gene, fatty acid binding protein 4 (FABP4).

16. the function of FABP4 in cervical cancer and the underlying molecular mechanisms, were investigated.

17. Elevation of FABP4 is associated with an increased risk of death and poor functional outcome events in patients with type 2 diabetes and acute ischemic stroke and is independent of other established clinical risk predictors and biomarkers

18. FABP4 shows potential as a novel biomarker for diabetic retinopathy prediction in Chinese patients with type 2 diabetes (T2DM), and strict glycemic control and more frequent retinal examination should be highlighted for T2DM patients with the highest quartile range of FABP4.

19. association between serum FABP4 concentrations and sarcopenia in chronic hemodialysis patients

20. intermittent high glucose potentiates A-FABP activation and inflammatory responses via TLR4/p-JNK signaling in THP-1 cells

Cow (Bovine) Fatty Acid Binding Protein 4, Adipocyte (FABP4) interaction partners

1. Studied SNPs in cattle Fatty Acid Binding Protein 4 (FABP4) in several cattle breeds and evaluated possible associations with regards to meat quality and fat content of the meat.

2. Overexpressed FABP4 of different genotypes in bovine intramuscular preadipocytes and studied the intracellular localization of FABP4 and the expression levels of lipid metabolism-related genes among different genotypes.

3. These results provide an important basis for further understanding the regulation of bovine FABP4.

4. This suggest that FABP4 affects milk yield and milk protein content, both economically important traits, and that further study of this gene is warranted.

5. Data show that overexpression of cattle adipocyte fatty acid-binding protein (A-FABP)gene promoted fat deposition in the skeletal muscle of transgenic mice.

6. FABP4 gene frequency and SNP genotypes in Holstein-Friesian cows and its relationship with protein and fat content in milk

7. polymorphisms can be used to select for milk with lower concentrations of saturated fatty acids and higher concentrations of unsaturated fatty acids

8. The effects of genetic polymorphisms of liver X receptor, alpha (LXR), stearoyl-CoA desaturase (SCD), Fatty acid synthase (FASN), and Fatty acid binding protein 4 (FABP4) were investigated on fatty acid composition in fat tissue of steers.

9. The results confirm the lack of an association found by many other studies and suggest that these SNPs are not influential on the divergent intramuscular fat levels in the crossbred population tested.

10. re-sequenced 4.3 kb of the FABP4 gene region in 24 Hanwoo bulls and identified 16 SNPs and 1 microsatellite polymorphism.

11. The FABP4 gene falls into a suggestive/significant quantitative trait loci interval for beef marbling.

12. Our findings suggest that the polymorphisms in FABP4 may play a role in determining one of the important genetic factors that influence back fat thickness in beef cattle.

13. FABP4 I74V polymorphism had a significant effect on palmitoleic acid composition in intramuscular fat.

14. A splice site single nucleotide polymorphism of the fatty acid binding protein 4 gene appears to be associated with intramuscular fat deposition in longissimus muscle in Australian cattle.

Pig (Porcine) Fatty Acid Binding Protein 4, Adipocyte (FABP4) interaction partners

1. FABP4 gene expression level in adipose tissue was higher than in muscle. In contrast, FABP5 was expressed at low levels in adipocytes and muscle tissues. Low and moderate correlations between FABP4 and FABP5 gene expression were observed in muscle and in backfat, respectively.

2. the A-FABP gene is strongly related to the development and function of intramuscular fat accretion in pigs.

3. AFABP is significantly increased in coronary artery in-stent restenosis segments of both diabetic and nondiabetic minipigs.

4. Thus A-FABP may be a candidate gene or a quantitative trait locus-linked gene associated with meat quality traits.

5. Monitoring of posttransplant L-FABP plasma levels is a valuable new tool to quantify early the extent of parenchymal cell damage of non-heart-beating donors in liver transplantation.

6. study suggests that FABP-4 protein content may be a valuable marker of lipid accretion

7. A study of the mapping characteristics and relationship to body composition of FAT1 and FABP4 in swine is reported.

8. regenerated coronary endothelial cells exhibit upregulation of adipocyte fatty acid binding protein (A-FABP)

Mouse (Murine) Fatty Acid Binding Protein 4, Adipocyte (FABP4) interaction partners

1. Macrophage-FABP4 has a novel role in pulmonary host defense against P. aeruginosa infection.

2. Genetic deletion of A-FABP successfully reduced tumor ALHD1 activation and obesity-associated mammary tumor growth and development in different mouse models.

3. Fabp4/5 knockout mice demonstrate that glucose is preferentially utilized for biomass synthesis rather than ATP production during pressure-overload-induced cardiac hypertrophy and that the efficient supplementation of energy substrates may restore cardiac dysfunction caused by energy insufficiency.

4. expression of FABP4 in eosinophils is induced during conditions of inflammation and plays a proinflammatory role in the development of allergic asthma by promoting eosinophil adhesion and migration and contributing to the development of various aspects of airway inflammation.

5. FABP4/5 have crucial roles in nutrient homeostasis during prolonged fasting for maintaining exercise endurance capacity.

6. Livers from obese mice, independent of tumour status, exhibited increased FABP4 mRNA and protein expression concomitant with elevated serum FABP4. The data suggest FABP4, an FABP not normally expressed in the liver, can be synthesized and secreted by hepatocytes and hepatocellular carcinoma cells, and that FABP4 may play a role in regulating tumour progression in the underlying setting of obesity.

7. results proved that the REV-ERB agonism inhibited osteoclastogenesis partially via FABP4 up-regulation.

8. The findings chart the pathway of FABP4 secretion and provide a potential therapeutic means to control metabolic disorders associated with its dysregulated secretion.

9. Study in A-FABP knockout mice revealed that A-FABP acts as a physiological stimulator of brown adipose tissue-mediated adaptive thermogenesis.

10. Fabp4/5 confers protection against metabolic diseases but does not extend lifespan.

11. Ectopic expression and secretion of FABP4 in vascular endothelial cells contribute to neointima formation after vascular injury.

12. FABP4 regulates the expression of BLT1R and its downstream signaling via control of oxidative stress in macrophages

13. Upregulated ROS induced by FABP4 was of significance in activating FoxM1 leading to airway inflammation and epithelial barrier dysfunction.

14. Collectively, these results demonstrate that C. pneumoniae exploits host FABP4 to facilitate fat mobilization and intracellular replication in adipocytes. This work uncovers a novel strategy used by intracellular pathogens for acquiring energy via hijacking of the host lipid metabolism pathway.

15. High Fabp4 expression is associated with Acute myeloid leukemia.

16. These data suggest that the function of SIRT6 in the Fabp4-Cre-expressing cells in addition to mature adipocytes plays a critical role in body weight maintenance and metabolic homeostasis.

17. This study demonstrating a FABP4-UCP2 axis with the potential to modulate the microglial inflammatory response.

18. our data establish A-FABP as a new molecular sensor in triggering macrophage-associated sterile inflammation in obesity.

19. these data offer a novel pathway whereby FABP4/aP2 regulates macrophage redox signaling and inflammasome activation via control of UCP2 expression.

20. FABP4 locally produced by epicardial/perivascular fat and macrophages in vascular plaques contributes to the development of coronary atherosclerosis.

Wheat germ Fatty Acid Binding Protein 4, Adipocyte (FABP4) interaction partners

1. Cloning and characterization of the gene and its homology with other species.

2. results indicated that an A-FABP gene polymorphism was associated with abdominal fat weight and percentage of abdominal fat, and the A-FABP gene could be a candidate locus or linked to a major gene(s) that affects abdominal fat content in the chicken